Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse

Learning and Memory

Volumn 10, Issue 2, 2003, Pages 116-128

  Azad, Shahnaz Christina ^a,b   Eder, Matthias ^a   Marsicano, Giovanni ^a   Lutz, Beat ^a   Zieglgänsberger, Walter ^a   Rammes, Gerhard ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ADENYLATE CYCLASE; AMPA RECEPTOR; CANNABINOID; CANNABINOID 1 RECEPTOR; GLUTAMATE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MALE; MEMORY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PATCH CLAMP; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

AMYGDALA; ANALGESICS; ANIMALS; CALCIUM CHANNELS; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MORPHOLINES; NAPHTHALENES; NEURAL INHIBITION; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RECEPTORS, AMPA; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, GABA-A; SYNAPTIC TRANSMISSION;

EID: 0037360828     PISSN: 10720502     EISSN: None     Source Type: Journal    
DOI: 10.1101/lm.53303     Document Type: Article

References (51)

1. Asztely, F., Xiao, M.Y., and Gustafsson, B. 1996. Long-term potentiation and paired-pulse facilitation in the hippocampal CA1 region. NeuroReport 7: 1609-1612.
2. Auclair, N., Otani, S., Soubrie, P., and Crepel, F. 2000. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J. Neurophysiol. 83: 3287-3293.
3. Becerra, L., Breiter, H.C., Wise, R., Gonzalez, R.G., and Borsook, D. 2001. Reward circuitry activation by noxious thermal stimuli. Neuron 32: 927-946.
4. + currents by 4-AP. J. Neurophysiol 82: 3476-3487.
5. Breivogel, C.S. and Childers, S.R. 1998. The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis. 5: 417-431.
6. +-channels. Ann. NY Acad. Sci. 868: 233-285.
7. Davis, M., Rainnie, D., and Cassell, M. 1994. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 17: 208-214.
8. Deadwyler, S.A., Hampson, R.E., Mu, J., Whyte, A., and Childers, S. 1995. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther. 273: 734-743.
9. Dodt, H.U., Eder, M., Schierloh, A., and Zieglgänsberger, W. 2002. Infrared-guided laser stimulation of neurons in brain slices. Sci. STKE 120: PL2.
10. Gauriau, C. and Bernard, J.F. 2002. Pain pathways and parabrachial circuits in the rat. Exp. Physiol. 87: 251-258.
11. Gerdeman, G.L., Ronesi, J., and Lovinger, D.M. 2002. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5: 446-451.
12. Glass, M. and Felder, C.C. 1997. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17: 5327-5333.
13. Hajos, N., Ledent, C., and Freund, T.F. 2001. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106: 1-4.
14. A synaptic transmission in the hippocampus. J. Neurosci. 20: 2470-2479.
15. - 2001. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: A comparison with opioids. J. Neurophysiol. 85: 72-83.
16. Howlett, A.C., Qualy, J.M., and Khachatrian, L.L. 1986. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29: 307-313.
17. Katona, I., Rancz, E.A., Acsady, L., Ledent, C., Mackie, K., Hajos, N., and Freund, T.F. 2001. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci. 21: 9506-9518.
18. Kreitzer, A.C. and Regehr, W.G. 2001. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29: 717-727.
19. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., et al. 1999. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404.
20. Mackie, K. and Hille, B. 1992. Cannabinoids inhibit N-type calcium-channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. 89: 3825-3829
21. Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R. 1995. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15: 6552-6561.
22. Manabe, T., Wyllie, D.J., Perkel, DJ., and Nicoll, R.A. 1993. Modulation of synaptic transmission and long-term potentiation: Effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus. J. Neurophysiol. 70: 1451-1459.
23. Maneuf, Y.P. and Brotchie, J.M. 1997. Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. Br. J. Pharmacol. 120:1397-1398.
24. Manning, B.H., Merin, N.M., Meng, I.D., and Amaral, D.G. 2001. Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. J. Neurosci. 21: 8238-8246.
25. Manzoni, O.J. and Bockaert, J. 2001. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur. J. Pharmacol. 412: R3-R5.
26. Marsicano, G. and Lutz, B. 1999. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11: 4213-4225.
27. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. 2002. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534.
28. Martin, W.J., Coffin, P.O., Attias, E., Balinsky, M., Tsou, K., and Walker, J.M. 1999. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res. 822: 237-242.
29. Mathie, A., Wooltorton, J.R.A., and Watkins, C.S. 1998. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen. Pharmacol. 30: 13-24.
30. McAllister, S.D., Griffin, G., Satin, L.S., and Abood, M.E. 1999. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium-channels in a Xenopus oocyte expression system. J. Pharmacol. Exp. Ther. 291: 618-626.
31. McDonald, A.J. and Mascagni, F. 2001. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: High concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 107: 641-652.
32. McKernan, M.G. and Shinnick-Gallagher, P. 1997. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature 390: 607-611.
33. Misner, D.L. and Sullivan, J.M. 1999. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19: 6795-6805.
34. Neugebauer, V. and Li. W. 2002. Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input. Neurophysiol. 87: 103-112.
35. Ohno-Shosaku, T., Maejima. T., and Kano, M. 2001. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neutron 29: 729-738.
36. Paulson, P.E., Casey, K.L., and Morrow, T.J. 2002. Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat. Pain 95: 31-40.
37. Pertwee, R.G. 2001. Cannabinoid receptors and pain. Prog. Neurobiol. 63:569-611.
38. Porter, A.C. and Felder, C.C. 2001. The endocannabinoid nervous system: Unique opportunities for therapeutic intervention. Pharmacol. Ther. 90: 45-60.
39. Robbe, D., Alonso, G., Duchamp, F., Bockaert, J., and Manzoni, O.J. 2001. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21: 109-116.
40. Rogan, M.T., Stäubli, U.V., and LeDoux, J.E. 1997. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604-607.
41. + M-current in hippocampal CA1 neurons. J. Neurosci. 20: 51-58.
42. 2+-channels by the spider toxin ω-agatoxin-IVA. J. Neurosci. 20: 7174-7182.
43. Sullivan, J.M. 1999. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol. 82: 1286-1294.
44. Swandulla, D. and Misgeld, U. 1990. Development and properties of synaptic mechanisms in a network of rat hypothalamic neurons grown in culture. J. Neurophysiol. 64: 715-726.
45. + (GIRK) currents in dendrites of rat neocortical pyramidal cells. J. Physiol. 517: 385-390
46. Twitchell, W., Brown, S., and Mackie, K. 1997. Cannabinoids inhibit N- and P/Q-type calcium-channels in cultured rat hippocampal neurons. J. Neurophysiol 78: 43-50.
47. Villemure, C. and Bushnell, M.C. 2002. Cognitive modulation of pain: How do attention and emotion influence pain processing? Pain 95: 195-199.
48. Washburn, M.S. and Moises. H.C. 1992. Electrophysiological and morphological properties of rat basolateral amygdaloid neurons in vitro. J. Neurosci. 12: 4066-4079.
49. Wilson, R.I. and Nicoll, R.A. 2001. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410: 588-592.
50. -. 2002. Endocannabinoid signaling in the brain. Science 296: 678-682.
51. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M., and Bonner, T.I. 1999. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. 96: 5780-5785.